Lomakina, Maria E
Lallemand, François
Vacher, Sophie
Molinie, Nicolas
Dang, Irene
Cacheux, Wulfran
Chipysheva, Tamara A
Ermilova, Valeria D
de Koning, Leanne
Dubois, Thierry
Bièche, Ivan
Alexandrova, Antonina Y
Gautreau, Alexis
Article History
Received: 8 December 2015
Accepted: 6 January 2016
First Online: 11 February 2016
Competing interests
: S.V., A.Y.A. and A.G. submitted a patent with the part of the current results showing that Arpin is frequently downregulated in breast cancer and that Arpin downregulation is associated with poor prognostic for patients. The patent was accepted by the European Patent Office (Patent EP 2842566 A1 priority 03/09/2013, published: 04/05/2015).